ORIC Revenue and Competitors
Estimated Revenue & Valuation
- ORIC's estimated annual revenue is currently $3.5M per year.
- ORIC's estimated revenue per employee is $87,500
Employee Data
- ORIC has 40 Employees.
- ORIC grew their employee count by -7% last year.
ORIC's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Regulation Officer, Office the Registrar Indigenous Corporations | Reveal Email/Phone |
2 | Registrar | Reveal Email/Phone |
ORIC Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $871.9M | 3165 | 30% | $246M | N/A |
#2 | $7.5M | 31 | 15% | N/A | N/A |
#3 | $3.5M | 67 | 12% | N/A | N/A |
#4 | $35M | 43 | -4% | N/A | N/A |
#5 | $7.5M | 123 | 31% | N/A | N/A |
#6 | $15M | 139 | 18% | N/A | N/A |
#7 | $15M | 36 | -5% | N/A | N/A |
#8 | $35M | 89 | -36% | N/A | N/A |
#9 | N/A | 38 | -22% | N/A | N/A |
#10 | $3.5M | 131 | 25% | N/A | N/A |
What Is ORIC?
The Registrar is an independent statutory office holder who administers the Corporations (Aboriginal and Torres Strait Islander) Act 2006. The Registrar's office supports and regulates corporations by: - advising on how to incorporate - training directors, members and key staff in good governance - ensuring compliance with the law - intervening when needed.
keywords:N/A
N/A
Total Funding
40
Number of Employees
$3.5M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ORIC News
On average, equities research analysts expect that ORIC Pharmaceuticals will post -2.61 EPS for the current fiscal year. Several equities...
Wall Street is positive on ORIC Pharmaceuticals Inc (ORIC). On average, analysts give the stock a Buy rating. The average price target is...
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage...
Other Companies in Phillip
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 59 | 0% | N/A |
#2 | $8.2M | 61 | -3% | N/A |
#3 | $15.3M | 92 | -1% | N/A |